![Thermo Fisher to acquire diagnostics firm Binding Site for $2.6B; plans $1B stock buyback | Seeking Alpha Thermo Fisher to acquire diagnostics firm Binding Site for $2.6B; plans $1B stock buyback | Seeking Alpha](https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1304276293/image_1304276293.jpg?io=getty-c-crop-4-3)
Thermo Fisher to acquire diagnostics firm Binding Site for $2.6B; plans $1B stock buyback | Seeking Alpha
![Organ transplant milestone as Thermo Fisher launches robust diagnostic technologies | HealthCare Middle East & Africa Magazine Organ transplant milestone as Thermo Fisher launches robust diagnostic technologies | HealthCare Middle East & Africa Magazine](https://www.healthcaremea.com/wp-content/uploads/2021/09/thermo-fisher-scientific-scholarship.jpg)
Organ transplant milestone as Thermo Fisher launches robust diagnostic technologies | HealthCare Middle East & Africa Magazine
![Thermo Fisher holds grand opening for new $85 million diagnostics center in Fremont – The Mercury News Thermo Fisher holds grand opening for new $85 million diagnostics center in Fremont – The Mercury News](https://www.mercurynews.com/wp-content/uploads/2016/08/20141030__sfrb1031thermofisher2.jpg?w=620)
Thermo Fisher holds grand opening for new $85 million diagnostics center in Fremont – The Mercury News
![Thermo Fisher Scientific signs Partnership Agreement with the new Terasaki Innovation Center for Transplant Diagnostic Research | World Pharma Today Thermo Fisher Scientific signs Partnership Agreement with the new Terasaki Innovation Center for Transplant Diagnostic Research | World Pharma Today](https://www.worldpharmatoday.com/wp-content/uploads/press-releases/13557/Thermo-Science-research.jpg)
Thermo Fisher Scientific signs Partnership Agreement with the new Terasaki Innovation Center for Transplant Diagnostic Research | World Pharma Today
![Thermo Fisher bets big on blood cancer, immune diagnostics with $2.6B Binding Site buyout - MedCity News Thermo Fisher bets big on blood cancer, immune diagnostics with $2.6B Binding Site buyout - MedCity News](https://medcitynews.com/uploads/2022/10/GettyImages-97206143-600x400.jpg)
Thermo Fisher bets big on blood cancer, immune diagnostics with $2.6B Binding Site buyout - MedCity News
![New IVD System Enables Assay Developers and Clinical Laboratories to Accelerate Molecular Diagnostics Growth New IVD System Enables Assay Developers and Clinical Laboratories to Accelerate Molecular Diagnostics Growth](https://mma.prnewswire.com/media/1488648/Thermo_Fisher_Scientific_Logo.jpg?p=facebook)
New IVD System Enables Assay Developers and Clinical Laboratories to Accelerate Molecular Diagnostics Growth
![Thermo Fisher Acquires Point-of-Care Molecular Diagnostics Provider Mesa Biotech - Industry News - Labmedica.com Thermo Fisher Acquires Point-of-Care Molecular Diagnostics Provider Mesa Biotech - Industry News - Labmedica.com](https://globetechcdn.com/labmedica/images/stories/articles/article_images/2021-01-20/SDD-2439C.jpg)
Thermo Fisher Acquires Point-of-Care Molecular Diagnostics Provider Mesa Biotech - Industry News - Labmedica.com
![Thermo Fisher to buy U.K. diagnostics firm The Binding Site Group for $2.6B - Boston Business Journal Thermo Fisher to buy U.K. diagnostics firm The Binding Site Group for $2.6B - Boston Business Journal](https://media.bizj.us/view/img/12323487/thermofisher-01*900xx6000-3375-0-313.jpg)